{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T03:28:59Z","timestamp":1790998139542,"version":"4.1.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:00:00Z","timestamp":1781740800000},"content-version":"am","delay-in-days":352,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100019892","name":"Pennsylvania Department of Human Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019892","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007921","name":"University of Pittsburgh","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007921","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA045675"],"award-info":[{"award-number":["R01DA045675"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA049759"],"award-info":[{"award-number":["R01DA049759"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.ajog.2024.12.001","type":"journal-article","created":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T02:50:54Z","timestamp":1733453454000},"page":"59.e1-59.e15","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Association between buprenorphine dose and outcomes among pregnant persons with opioid use disorder"],"prefix":"10.1016","volume":"233","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6907-5447","authenticated-orcid":false,"given":"Marian","family":"Jarlenski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Hsuan","family":"LoCiganic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingwen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabnum","family":"Pudasainy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie M.","family":"Donohue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evan S.","family":"Cole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth E.","family":"Krans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2024.12.001_bib1","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/AOG.0000000000002054","volume":"130","author":"Reddy","year":"2017","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2024.12.001_bib2","doi-asserted-by":"crossref","first-page":"3504","DOI":"10.1111\/add.15582","article-title":"Outcomes associated with the use of medications for opioid use disorder during pregnancy","volume":"116","author":"Krans","year":"2021","journal-title":"Addiction"},{"key":"10.1016\/j.ajog.2024.12.001_bib3","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.7964","article-title":"Association of duration of methadone or buprenorphine use during pregnancy with risk of nonfatal drug overdose among pregnant persons with opioid use disorder in the US","volume":"5","author":"Jarlenski","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ajog.2024.12.001_bib4","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1056\/NEJMoa2203318","article-title":"Buprenorphine versus methadone for opioid use disorder in pregnancy","volume":"387","author":"Suarez","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajog.2024.12.001_bib5","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s40263-015-0273-8","article-title":"Pharmacological management of opioid use disorder in pregnant women","volume":"29","author":"Wilder","year":"2015","journal-title":"CNS Drugs"},{"key":"10.1016\/j.ajog.2024.12.001_bib6","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1097\/AOG.0000000000003231","article-title":"Medication-assisted treatment use among pregnant women with opioid use disorder","volume":"133","author":"Krans","year":"2019","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2024.12.001_bib7","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1097\/ADM.0000000000000780","article-title":"Healthcare patterns of pregnant women and children affected by OUD in 9 state Medicaid populations","volume":"15","author":"Jarlenski","year":"2021","journal-title":"J Addict Med"},{"key":"10.1016\/j.ajog.2024.12.001_bib8","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/pds.4647","article-title":"Adherence trajectories of buprenorphine therapy among pregnant women in a large state Medicaid program in the United States","volume":"28","author":"Lo-Ciganic","year":"2019","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.ajog.2024.12.001_bib9","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1053\/j.semperi.2015.08.003","article-title":"Pharmacokinetics of drugs in pregnancy","volume":"39","author":"Feghali","year":"2015","journal-title":"Semin Perinatol"},{"key":"10.1016\/j.ajog.2024.12.001_bib10","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/FTD.0000000000000724","article-title":"Pregnancy alters CYP- and UGT-mediated metabolism of buprenorphine","volume":"42","author":"Zhang","year":"2020","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.ajog.2024.12.001_bib11","doi-asserted-by":"crossref","first-page":"459.e1","DOI":"10.1016\/j.ajog.2017.06.029","article-title":"An evidence-based recommendation to increase the dosing frequency of buprenorphine during pregnancy","volume":"217","author":"Caritis","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2024.12.001_bib12","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1111\/bcp.13642","article-title":"Gestational changes in buprenorphine exposure: a physiologically-based pharmacokinetic analysis","volume":"84","author":"Zhang","year":"2018","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.ajog.2024.12.001_bib13","doi-asserted-by":"crossref","first-page":"64.e1","DOI":"10.1016\/j.ajog.2016.09.095","article-title":"Dose-adjusted plasma concentrations of sublingual buprenorphine are lower during than after pregnancy","volume":"216","author":"Bastian","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2024.12.001_bib14","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1097\/EDE.0000000000001557","article-title":"Validation of ICD-10-CM diagnosis codes for gestational age at birth","volume":"34","author":"Leonard","year":"2022","journal-title":"Epidemiology"},{"key":"10.1016\/j.ajog.2024.12.001_bib15","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1377\/hlthaff.2019.00740","article-title":"Five-year outcomes among medicaid-enrolled children with in utero opioid exposure","volume":"39","author":"Jarlenski","year":"2020","journal-title":"Health Aff (Millwood)"},{"key":"10.1016\/j.ajog.2024.12.001_bib16","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.jclinepi.2012.04.010","article-title":"Classifying developmental trajectories over time should be done with great caution: a comparison between methods","volume":"65","author":"Twisk","year":"2012","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.ajog.2024.12.001_bib17","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1177\/0962280216673085","article-title":"Group-based multi-trajectory modeling","volume":"27","author":"Nagin","year":"2018","journal-title":"Stat Methods Med Res"},{"key":"10.1016\/j.ajog.2024.12.001_bib18","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1345\/aph.1H018","article-title":"Measurement of adherence in pharmacy administrative databases: a proposal for standard definitions and preferred measures","volume":"40","author":"Hess","year":"2006","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.ajog.2024.12.001_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.108317","article-title":"Adherence to buprenorphine: an analysis of prescription drug monitoring program data","volume":"216","author":"Pizzicato","year":"2020","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.ajog.2024.12.001_bib20","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1097\/AOG.0000000000002734","article-title":"Fatal and nonfatal overdose among pregnant and postpartum women in Massachusetts","volume":"132","author":"Schiff","year":"2018","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2024.12.001_bib21","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1097\/AOG.0000000000005117","article-title":"Initiation and treatment discontinuation of medications for opioid use disorder in pregnant people compared with nonpregnant people","volume":"141","author":"Xu","year":"2023","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2024.12.001_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.chiabu.2024.106798","article-title":"\u201cInstead of just taking my baby, they could've actually given me a chance\u201d: experiences with plans of safe care among birth parents impacted by perinatal substance use","volume":"152","author":"He","year":"2024","journal-title":"Child Abuse Negl"},{"key":"10.1016\/j.ajog.2024.12.001_bib23","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/YCO.0000000000000717","article-title":"The rise of illicit fentanyls, stimulants and the fourth wave of the opioid overdose crisis","volume":"34","author":"Ciccarone","year":"2021","journal-title":"Curr Opin Psychiatry"},{"key":"10.1016\/j.ajog.2024.12.001_bib24","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1097\/AOG.0000000000002562","article-title":"Opioid detoxification during pregnancy: a systematic review","volume":"131","author":"Terplan","year":"2018","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2024.12.001_bib25","doi-asserted-by":"crossref","first-page":"e81","DOI":"10.1097\/AOG.0000000000002235","article-title":"Committee Opinion No. 711: opioid use and opioid use disorder in pregnancy","volume":"130","year":"2017","journal-title":"Obstet Gynecol"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937824011785?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937824011785?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T10:38:08Z","timestamp":1762079888000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937824011785"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S0002937824011785"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2024.12.001","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association between buprenorphine dose and outcomes among pregnant persons with opioid use disorder","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2024.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}